Skip to main content

EU promises speedy review of remdesivir

The European health regulator has vowed to conduct a speedy review of Gilead Sciences' potential COVID-19 drug, remdesivir, but says it has not yet received an application from the US drugmaker.

from Breaking News | Daily Telegraph https://ift.tt/3dfAW2l

Comments

Popular posts from this blog

El valor del bitcóin alcanza los 100.000 dólares

By David Yaffe-Bellany from NYT En español https://ift.tt/4oaX5Yi

Pagers Belonging to Hezbollah Militants Explode Across Lebanon

By Axel Boada from NYT World https://ift.tt/8etf4Yr

Pelosi Hospitalized in Luxembourg After Falling

By Annie Karni from NYT U.S. https://ift.tt/OM3CtY5